Breder, I., Cunha Breder, J., Bonilha, I., Munhoz, D. B., Medorima, S. T. K., Oliveira, D. C., . . . Sposito, A. C. (2020). Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial. Ther Adv Chronic Dis.
Style de citation ChicagoBreder, Ikaro, et al. "Rationale and Design of the Expanded Combination of Evolocumab Plus Empagliflozin in Diabetes: EXCEED-BHS3 Trial." Ther Adv Chronic Dis 2020.
Style de citation MLABreder, Ikaro, et al. "Rationale and Design of the Expanded Combination of Evolocumab Plus Empagliflozin in Diabetes: EXCEED-BHS3 Trial." Ther Adv Chronic Dis 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.